Liu L, Shi Z, Ji X, Zhang W, Luan J, Zahr T, et al. Adipokines, adiposity, and atherosclerosis. Cell Mol Life Sci. 2022;79(5):272. https://doi.org/10.1007/s00018-022-04286-2.
Article CAS PubMed Google Scholar
Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852–66. https://doi.org/10.1161/circresaha.114.302721.
Article CAS PubMed Google Scholar
Montarello NJ, Nguyen MT, Wong DTL, Nicholls SJ, Psaltis PJ. Inflammation in coronary atherosclerosis and its therapeutic implications. Cardiovasc Drugs Ther. 2022;36(2):347–62. https://doi.org/10.1007/s10557-020-07106-6.
Article CAS PubMed Google Scholar
Bai Y, Sun Q. Macrophage recruitment in obese adipose tissue. Obes Rev. 2015;16(2):127–36. https://doi.org/10.1111/obr.12242.
Article CAS PubMed PubMed Central Google Scholar
Maddux BA, See W, Lawrence JC Jr., Goldfine AL, Goldfine ID, Evans JL. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes. 2001;50(2):404–10. https://doi.org/10.2337/diabetes.50.2.404.
Article CAS PubMed Google Scholar
Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004;24(5):816–23. https://doi.org/10.1161/01.Atv.0000122852.22604.78.
Article CAS PubMed Google Scholar
Zhou Y, Wei Y, Wang L, Wang X, Du X, Sun Z, et al. Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease. Cardiovasc Diabetol. 2011;10:2. https://doi.org/10.1186/1475-2840-10-2.
Article CAS PubMed PubMed Central Google Scholar
Kawano J, Arora R. The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr. 2009;4(1):44–9. https://doi.org/10.1111/j.1559-4572.2008.00030.x.
Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, et al. Adiponectin in relation to exercise and physical performance in patients with type 2 diabetes and coronary artery disease. Adipocyte. 2021;10(1):612–20. https://doi.org/10.1080/21623945.2021.1996699.
Article CAS PubMed PubMed Central Google Scholar
Fadaei R, Moradi N, Kazemi T, Chamani E, Azdaki N, Moezibady SA, et al. Decreased serum levels of CTRP12/adipolin in patients with coronary artery disease in relation to inflammatory cytokines and insulin resistance. Cytokine. 2019;113:326–31. https://doi.org/10.1016/j.cyto.2018.09.019.
Article CAS PubMed Google Scholar
Schäffler A, Buechler C. CTRP family: linking immunity to metabolism. Trends Endocrinol Metab. 2012;23(4):194–204. https://doi.org/10.1016/j.tem.2011.12.003.
Article CAS PubMed Google Scholar
Lei X, Seldin MM, Little HC, Choy N, Klonisch T, Wong GW. C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance. J Biol Chem. 2017;292(36):14836–50. https://doi.org/10.1074/jbc.M116.766808.
Article CAS PubMed PubMed Central Google Scholar
Wang M, Tang X, Li L, Liu D, Liu H, Zheng H, et al. C1q/TNF-related protein-6 is associated with insulin resistance and the development of diabetes in Chinese population. Acta Diabetol. 2018;55(12):1221–9. https://doi.org/10.1007/s00592-018-1203-2.
Article CAS PubMed Google Scholar
Zheng WF, Zhang SY, Ma HF, Chang XW, Wang H. C1qTNF-related protein-6 protects against doxorubicin-induced cardiac injury. J Cell Biochem. 2019;120(6):10748–55. https://doi.org/10.1002/jcb.28366.
Article CAS PubMed Google Scholar
Murayama MA, Kakuta S, Inoue A, Umeda N, Yonezawa T, Maruhashi T, et al. CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis. Nat Commun. 2015;6(1):1–12.
Kim MJ, Lee W, Park EJ, Park SY. C1qTNF-related protein-6 increases the expression of interleukin-10 in macrophages. Mol Cells. 2010;30(1):59–64. https://doi.org/10.1007/s10059-010-0088-x.
Article CAS PubMed Google Scholar
Lei H, Wu D, Wang J-Y, Li L, Zhang C-L, Feng H, et al. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation. Basic Res Cardiol. 2015;110(4):35. https://doi.org/10.1007/s00395-015-0492-7.
Article CAS PubMed Google Scholar
Wei C, Liu Y, Xing E, Ding Z, Tian Y, Zhao Z, et al. Association between Novel Pro- and Anti- Inflammatory adipocytokines in patients with Acute Coronary Syndrome. Clin Appl Thromb Hemost. 2022;28:10760296221128021. https://doi.org/10.1177/10760296221128021.
Article CAS PubMed PubMed Central Google Scholar
Emamgholipour S, Moradi N, Beigy M, Shabani P, Fadaei R, Poustchi H, et al. The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case-control study. Diabetol Metab Syndr. 2015;7:108. https://doi.org/10.1186/s13098-015-0099-z.
Article CAS PubMed PubMed Central Google Scholar
Fadaei R, Moradi N, Baratchian M, Aghajani H, Malek M, Fazaeli AA, et al. Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 serum levels with coronary artery disease in subjects with and without type 2 diabetes Mellitus. PLoS ONE. 2016;11(12):e0168773. https://doi.org/10.1371/journal.pone.0168773.
Article CAS PubMed PubMed Central Google Scholar
Bai B, Ban B, Liu Z, Zhang MM, Tan BK, Chen J. Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in type 2 diabetes mellitus: in vivo regulation by glucose. PLoS ONE. 2017;12(2):e0172271.
Article PubMed PubMed Central Google Scholar
Seldin MM, Tan SY, Wong GW. Metabolic function of the CTRP family of hormones. Reviews Endocr Metabolic Disorders. 2014;15(2):111–23. https://doi.org/10.1007/s11154-013-9255-7.
Lu L, Zhang RY, Wang XQ, Liu ZH, Shen Y, Ding FH, et al. C1q/TNF-related protein-1: an adipokine marking and promoting atherosclerosis. Eur Heart J. 2016;37(22):1762–71.
Moradi N, Fadaei R, Emamgholipour S, Kazemian E, Panahi G, Vahedi S, et al. Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease. PLoS ONE. 2018;13(1):e0192159.
Article PubMed PubMed Central Google Scholar
Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Revett T, Gimeno R, Lodish HF. Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J. 2008;416(2):161–77. https://doi.org/10.1042/bj20081240.
Article CAS PubMed Google Scholar
Xu E, Yin C, Yi X, Liu Y. Knockdown of CTRP6 inhibits high glucose-induced oxidative stress, inflammation and extracellular matrix accumulation in mesangial cells through regulating the Akt/NF‐κB pathway. Clin Exp Pharmacol Physiol. 2020;47(7):1203–11.
Article CAS PubMed Google Scholar
Lee W, Kim MJ, Park EJ, Choi YJ, Park SY. C1qTNF-related protein-6 mediates fatty acid oxidation via the activation of the AMP-activated protein kinase. FEBS Lett. 2010;584(5):968–72. https://doi.org/10.1016/j.febslet.2010.01.040.
Article CAS PubMed Google Scholar
Sadeghi A, Fadaei R, Moradi N, Fouani FZ, Roozbehkia M, Zandieh Z et al. Circulating levels of C1q/TNF-α-related protein 6 (CTRP6) in polycystic ovary syndrome. 2020;72(7):1449–59; https://doi.org/10.1002/iub.2272.
Liao X, Liu S, Tang X, Yang D, Liu H, Gao L, et al. Circulating CTRP6 levels are increased in overweight or obese Chinese individuals and Associated with insulin resistance parameters: a pilot study. Experimental and clinical endocrinology & diabetes: official journal. German Soc Endocrinol [and] German Diabetes Association. 2021;129(7):535–41. https://doi.org/10.1055/a-0929-6072.
Wu WJ, Mo DL, Zhao CZ, Zhao C, Chen YS, Pang WJ, et al. Knockdown of CTRP6 inhibits adipogenesis via lipogenic marker genes and Erk1/2 signalling pathway. Cell Biol Int. 2015;39(5):554–62. https://doi.org/10.1002/cbin.10422.
Article CAS PubMed Google Scholar
Wu W, Sun Y, Zhao C, Zhao C, Chen X, Wang G, et al. Lipogenesis in myoblasts and its regulation of CTRP6 by AdipoR1/Erk/PPARγ signaling pathway. Acta Biochim Biophys Sin. 2016;48(6):509–19.
Article CAS PubMed PubMed Central Google Scholar
Li Y, Sun J, Gu L, Gao X. Protective effect of CTRP6 on cerebral ischemia/reperfusion injury by attenuating inflammation, oxidative stress and apoptosis in PC12 cells. Mol Med Rep. 2020;22(1):344–52. https://doi.org/10.3892/mmr.2020.11108.
Article CAS PubMed PubMed Central Google Scholar
Xu E, Yin C, Yi X, Liu Y. Knockdown of CTRP6 inhibits high glucose-induced oxidative stress, inflammation and extracellular matrix accumulation in mesangial cells through regulating the Akt/NF-κB pathway. Clin Exp Pharmacol Physiol. 2020;47(7):1203–11. https://doi.org/10.1111/1440-1681.13289.
留言 (0)